Helping you make wiser investment decisions

After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl

March 17, 2022 aliu



After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl
aliu
Thu, 03/17/2022 – 08:53



Source link